No abstract available
MeSH terms
-
Administration, Oral
-
Benzenesulfonates / administration & dosage
-
Benzenesulfonates / adverse effects*
-
Benzenesulfonates / therapeutic use
-
Erythema Multiforme / chemically induced*
-
Female
-
Humans
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / secondary
-
Melanoma, Amelanotic / drug therapy
-
Melanoma, Amelanotic / secondary
-
Middle Aged
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / adverse effects*
-
Protein Kinase Inhibitors / therapeutic use
-
Pyridines / administration & dosage
-
Pyridines / adverse effects*
-
Pyridines / therapeutic use
-
Sorafenib
Substances
-
Benzenesulfonates
-
Phenylurea Compounds
-
Protein Kinase Inhibitors
-
Pyridines
-
Niacinamide
-
Sorafenib